Table 2.
Change from Baseline to Week 36 | MI | AC | p-value |
---|---|---|---|
Improvement in SF36 physical function | |||
Opioid users | 10.25 (1.94) | 7.00 (1.87) | 0.234 |
Opioid non-users | 14.47 (1.23) | 9.66 (1.22) | 0.006* |
Reduction in BPI pain severity | |||
Opioid users | -0.80 (0.17) | -0.76 (0.16) | 0.930 |
Opioid non-users | -1.49 (0.12) | -0.98 (0.12) | 0.004* |
Improvement in global FM severity (FIQ total) | |||
Opioid users | -9.60 (1.71) | -9.49 (1.66) | 0.963 |
Opioid non-users | -15.47 (1.21) | -11.85 (1.20) | 0.036* |
Increase in light-moderate physical activity# | |||
Opioid users | 3.64 (0.84) | 3.26 (0.82) | 0.746 |
Opioid non-users | 4.68 (0.52) | 3.01 (0.51) | 0.023* |
Values are means (standard errors) adjusted for baseline outcome and body mass index
P<0.05; Analyses included subjects (N=198, 92% of 216) with 6-month follow-up data.
Number of hours per week
MI=motivational interviewing, AC=Attention control